Balancing the Benefits of the New Anti-Obesity Medications with their Exorbitant Costs: What is a Self-Funded Employer to do? 

Abacus' Sr Scientist, David Ahern, PhD and his Co-Authors: Collin Smith, PharmD, Augustus E. Adams, PhD, Michael J. Follick, PhD recently penned an opinion piece on the Obesity epidemic and its effects on self-funded employers. The article published on Healthcare Business Today, explored the impacts of obesity on self-funded employer...